Cardiac myocytes control release of endothelin-1 in coronary vasculature

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  Merkus, Daphne ^a   Brzezinska, Anna K ^b   Zhang, Cuihua ^b   Saito, Shuichi ^b   Chilian, William M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary blood flow; Coronary circulation; Coronary microcirculation; Vasoconstriction

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; ETHIDIUM BROMIDE; JKC 301; LOSARTAN; PHENYLEPHRINE; PHOSPHORAMIDON; PREPROENDOTHELIN; UNCLASSIFIED DRUG;

ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DOSE RESPONSE; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASOCONSTRICTION; VASODILATATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ARTERIOLES; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIN-1; MALE; MICROCIRCULATION; MYOCYTES, CARDIAC; PHENYLEPHRINE; RATS; RATS, WISTAR; VASOCONSTRICTION;

EID: 18044378598     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00522.2003     Document Type: Article

References (23)

1. 1-adrenergic constriction of coronary arterioles. Am J Physiol Heart Circ Physiol 276: H1028-H1034, 1999.
2. Duncker DJ and Bache RJ. Regulation of coronary vasomotor tone under normal conditions and during acute myocardial hypoperfusion. Pharmacol Ther 86: 87-110, 2000.
3. Duncker DJ, Stubenitsky R, and Verdouw PD. Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feed-forward β-adrenergic control. Circ Res 82: 1312-1322, 1998.
4. Ergul A. Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents. Pharmacotherapy 22: 54-65, 2002.
5. Garcia JL, Fernandez N, Garcia-Villalon AL, Monge L, Gomez B, and Dieguez G. Coronary vasoconstriction by endothelin-1 in anesthetized goats: role of endothelin receptors, nitric oxide and prostanoids. Eur J Pharmacol 315: 179-186, 1996.
6. Garlichs CD, Zhang H, Mugge A, and Daniel WG. Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells. Eur J Clin Invest 29: 12-16, 1999.
7. Heusch G, Baumgart D, Camici P, Chilian W, Gregorini L, Hess O, Indolfi C, and Rimoldi O. α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation 101: 689-694, 2000.
8. Heusch G and Deussen A. The effects of cardiac sympathetic nerve stimulation on perfusion of stenotic coronary arteries in the dog. Circ Res 53: 8-15, 1983.
9. Hurlimann D, Enselelt F, Noll G, Luscher TF, and Ruschitzka F. Endothelin antagonists and heart failure. Curr Hypertens Rep 4: 85-92, 2002.
10. Kuo L, Davis MJ, and Chilian WM. Myogenic activity in isolated subepicardial and subendocardial coronary arterioles. Am J Physiol Heart Circ Physiol 255: H1558-H1562, 1988.
11. Lavallee M, Takamura M, Parent R, and Thorin E. Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail Rev 6: 265-276, 2001.
12. Merkus D, Duncker DJ, and Chilian WM. Metabolic regulation of coronary vascular tone: role of endothelin-1. Am J Physiol Heart Circ Physiol 283: H1915-H1921, 2002.
13. Mohrman DE and Feigl EO. Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res 42: 79-86, 1978.
14. 1-Receptor localization in rat heart and kidney using autoradiography. Am J Physiol Heart Circ Physiol 249: H512-H519, 1985.
15. Neri Serneri GG, Boddi M, Modesti PA, Cecioni I, Coppo M, Padeletti L, Michelucci A, Colella A, and Gaianti G. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res 89: 977-982, 2001.
16. Piper HM, Volz A, and Schwartz P. Adult ventricular rat heart muscle cells. In: Cell Techniques in Heart and Vessel Research, edited by Piper HM. Heidelberg: Springer, 1990, p. 36-60.
17. Preisig-Muller R, Mederos y Schnitzler M, Derst C, and Daut J. Separation of cardiomyocytes and coronary endothelial cells for cell-specific RT-PCR. Am J Physiol Heart Circ Physiol 277: H413-H416, 1999.
18. Shimizu K and McGrath BP. Sympathetic dysfunction in heart failure. Baillieres Clin Endocrinol Metab 7: 439-463, 1993.
19. Stepp DW, Merkus D, Nishikawa Y, and Chilian WM. Nitric oxide limits coronary vasoconstriction by a shear stress-dependent mechanism. Am J Physiol Heart Circ Physiol 281: H796-H803, 2001.
20. 1-adrenergic constriction. Circulation 98: 9-12, 1998.
21. Van Haperen R, Cheng C, Mees BM, van Deel E, de Waard M, van Damme LC, van Gent T, van Aken T, Krams R, Duncker DJ, and de Crom R. Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice. Am J Pathol 163: 1677-1686, 2003.
22. Wang Y, Kanatsuka H, Akai K, Sugimura A, Kumagai T, Komaru T, Sato K, and Shirato K. Effects of low doses of endothelin-1 on basal vascular tone and autoregulatory vasodilation in canine coronary microcirculation in vivo. Jpn Circ J 63: 617-623, 1999.
23. Winegrad S, Henrion D, Rappaport L, and Samuel JL. Self-protection by cardiac myocytes against hypoxia and hyperoxia. Circ Res 85: 690-698, 1999.